
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes

Tuesday Mar 28, 2023
Tuesday Mar 28, 2023
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the role of biomarkers in optimizing the treatment of colorectal cancer, and how biomarkers are shaping the evolving treatment landscape.
The experts
- Dr Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan
- Dr Chiara Cremolini, University of Pisa, Pisa, Italy
- Dr Rachel Riechelmann, AC Camargo Cancer Center, São Paulo, Brazil
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchoncologyime.org/pd-treatment-of-crc-in-the-biomarker-era/

Monday Mar 27, 2023
Monday Mar 27, 2023
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team review novel approaches to overcome resistance to standard-of-care immunotherapy for non-driver mutation metastatic NSCLC, including new immune checkpoint inhibitor combinations and emerging novel targets.
The multidisciplinary team:
- Oncology Pharmacist: Prof. Lisa Holle, University of Connecticut School of Medicine, Storrs, and UConn Health: Neag Comprehensive Cancer Center, Farmington, CT, USA
- Medical Oncologist: Prof. Raffaele Califano, The Christie and Manchester University Hospital, Manchester, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-immunotherapies-for-metastatic-nsclc-without-driver-mutations/

Monday Mar 27, 2023
Monday Mar 27, 2023
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the tools used to predict response to immunotherapy, and they review emerging biomarkers.
The multidisciplinary team:
- Pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Heidelberg, Germany
- Medical Oncologist: Prof. Raffaele Califano, The Christie and Manchester University Hospital, Manchester, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-immunotherapies-for-metastatic-nsclc-without-driver-mutations/

Monday Mar 27, 2023
Monday Mar 27, 2023
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team, plus a survivor of metastatic NSCLC, discuss the importance of involving patients in their treatment decisions and how clinicians can best support patients throughout their treatment journey.
The multidisciplinary team:
- Medical Oncologist: Prof. Raffaele Califano, The Christie and Manchester University Hospital, Manchester, UK
- Oncology Pharmacist: Prof. Lisa Holle, University of Connecticut School of Medicine, Storrs, and UConn Health: Neag Comprehensive Cancer Center, Farmington, CT, USA
- Patient Advocate: Mr Josh Colow, Woodstock, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-immunotherapies-for-metastatic-nsclc-without-driver-mutations/

Monday Mar 27, 2023
Monday Mar 27, 2023
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the challenges associated with standard-of-care immunotherapy for metastatic NSCLC without driver mutations, including treatment resistance and toxicity.
The multidisciplinary team:
- Medical Oncologist: Prof. Raffaele Califano, The Christie and Manchester University Hospital, Manchester, UK
- Oncology Pharmacist: Prof. Lisa Holle, University of Connecticut School of Medicine, Storrs, and UConn Health: Neag Comprehensive Cancer Center, Farmington, CT, USA
- Pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Heidelberg, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-immunotherapies-for-metastatic-nsclc-without-driver-mutations/

Friday Mar 24, 2023
Friday Mar 24, 2023
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to a panel of leading experts discuss the burden and clinical presentation of pyruvate kinase (PK) deficiency, the current treatment strategies and remaining unmet treatment need, and future approaches to managing the disease.
The experts:
- Dr Rachael Grace, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA
- Dr Hanny Al-Samkari, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- Prof. Ami J Shah, Lucile Packard Children’s Hospital Stanford, and Stanford University, Palo Alto, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Agios Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchhaematologyime.org/pd-navigating-pyruvate-kinase-deficiency-today/

Thursday Mar 23, 2023
Thursday Mar 23, 2023
touchPANEL DISCUSSION for touchENDOCRINOLOGY
Listen to a radiologist, a nephrologist and a primary care physician discuss how to predict progression and prognosis in ADPKD, as well as current and emerging treatment options for rapidly progressing disease, and how to manage potential side effects.
The experts:
- Prof. Bradley Erickson, Mayo Clinic College of Medicine and Science, Rochester, MN, USA;
- Prof. Neera Dahl, Yale University, Yale School of Medicine, New Haven, CT, USA;
- Prof. Charles Vega, UCI Health, Santa Ana, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Otsuka America Pharmaceutical, Inc. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchendocrinologyime.org/clinical-management-of-rapidly-progressing-ADPKD

Tuesday Mar 21, 2023
Tuesday Mar 21, 2023
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the burden and clinical presentation of pyruvate kinase (PK) deficiency, the current treatment strategies and remaining unmet treatment need, and future approaches to managing the disease.
The experts
- Dr Rachael Grace, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA
- Dr Hanny Al-Samkari, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- Prof. Ami J Shah, Lucile Packard Children’s Hospital Stanford, and Stanford University, Palo Alto, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Agios Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit: TBC

Tuesday Mar 14, 2023
MDT and patient advocate perspectives on the key signs and symptoms of DMD
Tuesday Mar 14, 2023
Tuesday Mar 14, 2023
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team, plus a patient advocate who is the parent of a patient with DMD, discuss the traditional and non-traditional signs and symptoms of the condition.
The multidisciplinary team:
- Paediatrician: Dr Laura Kauffman, Weissbluth Pediatrics, Chicago, IL, USA
- Neurologist: Prof. Nancy Kuntz, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Patient advocate: Mr Filippo Buccella, Parent Project APS, Rome, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/mdt-insights-on-modern-medical-management-in-patients-with-dmd/

Tuesday Mar 14, 2023
MDT and patient advocate perspectives on diagnosing DMD and how to screen
Tuesday Mar 14, 2023
Tuesday Mar 14, 2023
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team, plus a patient advocate who is the parent of a patient with DMD, discuss the key considerations for the diagnosis of DMD and pre-symptomatic screening for the condition.
The multidisciplinary team:
- Neurologist: Prof. Nancy Kuntz, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Geneticist: Dr Nadia Merchant, Children’s National Hospital, Washington, DC, USA
- Patient advocate: Mr Filippo Buccella, Parent Project APS, Rome, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/mdt-insights-on-modern-medical-management-in-patients-with-dmd